Bal Pharma Limited

To be Global Research Driven Company with a strong R & D pipeline.

Is dedicated to the pursuit of providing better and healthy lifestyle through quality products and innovation.

Unit -1
 Bal Pharma Unit - 1 :   finished dosage facility for manufacturing Tablets, Capsules, Ointments. The manufacturing plant is WHO-GMP approved and has obtained the ISO 9001:2000 accreditations.

The products are exported to South East Asian countries, African countries, Middle East, and Latin American markets. The plant also caters to the needs of companies for Contract Manufacturing both in India and Abroad.

The manufacturing facility is approved by the Ministry of Health – Ethiopia , MCAZ-Zimbabwe , Tanzania Food and Drug Authority and the plant is awaiting approval from Kenya - Pharmacy and Poisons Board, Ministry of Health – Malawi .

Unit - 2
 Bal Pharma Unit - 2 :  is involved in the manufacturing of API’s. All activities connected with production of bulk actives are carried out here. A well-equipped R&D laboratory, a good Kilo laboratory and quality control facilities form the other spheres of activity here. A well-trained team of about 40 personnel man the different departments of the facility.

Many of the processes that have been developed in the laboratory have been scaled up and have attained bulk production levels. or export of Gliclazide to Europe,Bal Pharma’s facility has obtained the approval from Europe’s EDQM and the Certificate of Suitability has been received.

Over the years, we have gained experience in carrying out different kinds of reactions, a concise list of which is appended at the end. At our facility the emphasis has been on producing important high value-low volume category of drugs and their intermediates. Our expertise in benzodiazepinones, steroidal drugs, nutraceuticals, antidepressants,antihistamines and cardiovascular drugs has been well recognised. We now are making an initial foray into the chiral molecule segment; stereospecific synthesis is on the agenda.

The API products are being exported to Japan, Australia, Spain, UK, Canada, Nigeria, Iceland, Slovenia, Romania, Argentina, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, Turkey, Egypt, Korea, Venezuela, Italy, Portugal, Morocco, Poland, Netherlands, Syria, Bangladesh, and Indonesia etc.

Unit - 3
The Bal Pharma Unit - 3 :   manufacturers Liquid Oral preparations, Large Volume  Parenterals and Small Volume Parenterals using FFS technology. The manufacturing plant is designed as per WHO-GMP guidelines.

The LVP and SVP are being exported to many African and Asian countries and also cater to the needs of companies for Contract Manufacturing both in India and Abroad.

The manufacturing facility is approved by the Ministry of Health – Ethiopia , MCAZ- Zimbabwe and the plant is awaiting approval from NAFDAC - Nigeria , PPB – Kenya and FDB – Ghana .

Unit - 4
The Bal Pharma Unit - 4 :  is a new manufacturing plant build at the cost of USD 8 Million. The plant is designed as per the USFDA and MHRA guidelines. The plant has ultramodern machineries for the manufacturing of Tablets, Capsules and Ointments.

India
Bal Pharma is committed to provide Innovative solutions in disease management, by providing Quality medicines.

Bal Pharma promotes various prescription medicines and generics. We look for providing innovative solution. Our speciality products that can satisfy medical needs and contribute to the health care industry.

Bal Pharma remains in the forefront with major treatments for Diabetes, Cardiometabolics, Gynaecology, Dermatology, Gastroenterology, Orthopaedics, ENT, Multi-speciality.

Our mission governs the way we do business, the products we manufacture, develop, and the way we train our employees to reach our best efforts and skills.

Bal Pharma operates its domestic marketing through 5 divisions namely Multi-Specialty, Glyduz, Servetus, Bal Vedics and Zennova . 

To facilitate the marketing of above , we operates via, a nation wide distribution network of 1000 wholesalers who in turn caters over 1, 00, 000 retailers.

Our 600 Professional team represents and promote our products to meet 1,00,000 doctors throughout the country.

International
Bal Pharma API (Active Pharmaceutical Ingredients) business began in 1996 with a simple objective of facilitating the manufacture of niche molecules which have been able to take the benefits of vertical integration to international and domestic markets.

The Bal Pharma’s API business has the competence and knowledge to undertake more than 30 different types of complex chemical reactions. Whether it is advance intermediates, fine chemicals or active pharmaceuticals ingredients, the company can seamlessly scale up from mg to MT quantities. It offers various activities.

• State of the art pilot and commercial scale multi purpose facilities.
• Pharmaceutical manufacturing plants conforming to GMP guidelines.
• R & D facilities to support early development of generic APIs.
• Patent non infringing processes.
• High quality documents – Drug master file.

The API products are being exported to Japan, Australia, Spain, UK, Canada, Nigeria, Iceland, Slovenia, Romania, Argentina, Brazil, Pakistan, Germany, South Africa, Serbia, Taiwan, Malaysia, Thailand, Turkey, Egypt, Korea, Venezuela, Italy, Portugal, Morocco, Poland, Netherlands, Syria, Bangladesh, and Indonesia etc.

The range of APIs includes Anti Histamine, Platelet inhibitor, Antidiabetic, Anti Convulsant, urinary incontinence, Neuropathic pain, Anti allergy, Anti inflammatory, Diuretic, Acne Treatment etc.

The plant has various accreditations.

The Research and Development laboratory at Bal Pharma Limited is involved in the development of processes for novel bulk actives (active pharmaceutical ingredients, APIs). This comprises of optimization of methods of synthesis of products that are of interest and demand in national and international markets as also conducting investigations on the development of new chemical substances for therapeutic applications. All this work is carried out by highly qualified and trained personnel who constantly are involved in the study of important drugs in different medicinal segments.

The Research & Development laboratory of Bal Pharma Limited has been recognized by the Department of Scientific and Industrial Research, Government of India.

The company possesses very good facilities for carrying out scale up operations of chemical processes developed in the laboratories to pilot plant scales and subsequently to bulk manufacturing levels.

The analytical services laboratory is manned by experienced and qualified chemists who provide support to the different departments involved in chemical process operations at the plant. The support activities include close monitoring of the nature and quality of products under production, development of analytical procedures for new chemical entities with thorough validation exercise backup, aiding the R & D personnel in the physical methods of analysis for structure elucidation and characterization of new chemical substances. A state-of-the-art instrumentation laboratory meets the analytical needs of the synthetic team.